BGBIO — Bergenbio ASA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Bergenbio ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	722	437	151	156	140
Net Total Receivables	13.5	11.7	14.1	10.1	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	736	449	167	174	155
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.33	1.19	0.043	0.431	1.25
Other Long Term Assets
Total Assets	738	450	167	174	156
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	66.6	64.9	77.9	46.9	32.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	68	65.8	78.2	46.9	33.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	670	384	88.5	127	123
Total Liabilities & Shareholders' Equity	738	450	167	174	156
Total Common Shares Outstanding